Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 25, 2025
SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) Announces Halo Spin-Out Distribution for Stockholders of Record as of April 23, 2025
GlobeNewswire
·
April 25, 2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (NYSE American: BTTR) (the “Company”), a leading global health and wellness company, today announced that it will distribute (the “ …
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
GlobeNewswire
·
April 25, 2025
Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co- …
EPC-RPU: AI-Powered Embedded System for Automation, Retail, and Healthcare
EIN Presswire
·
April 25, 2025
TAIPEI, TAIWAN, April 25, 2025 /EINPresswire.com/ -- Avalue Technology Inc. (TAIEX: 3479-TW), a global leader in industrial computing solutions, has officially announced its latest high-performance embedded system EPC-RPU, featuring the Intel® 13th …
Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)
GlobeNewswire
·
April 25, 2025
New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such pill is Clenbuterol, which is often used for weight loss. However, Clenbuterol …
Board Certified Plastic Surgeon, Clark Schierle, MD, PhD, FACS Approved As 2025 IL Top Doc
EIN Presswire
·
April 25, 2025
Dr. Clark Schierle of Northwestern Specialists in Plastic Surgery has been reviewed and approved based on merit by IL Top Docs for 2025. CHICAGO, IL, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Board Certified Plastic Surgeon, Clark Schierle, MD …
Board Certified Dermatologist, Dr. Adriana Lombardi Awarded As 2025 NJ Top Doc
EIN Presswire
·
April 25, 2025
NJ Top Docs has reviewed and approved Dr. Adriana Lombardi based on merit for 2025. EDISON, NJ, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- Board Certified Dermatologist, Dr. Adriana Lombardi Awarded As 2025 NJ Top Doc NJ Top Docs has …
NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1
EIN Presswire
·
April 25, 2025
Confirmation of NP137 Potential to Overcome Resistance to Immune Checkpoint - Clinical Trial Design and Interim Results to be Presented at ASCO and ESMO 2025 LYON, FRANCE, April 25, 2025 /EINPresswire.com/ -- NETRIS Pharma, a clinical-stage private …
New Book Explores the Role of AI, Telemedicine, and Big Data in Modern Healthcare
EIN Presswire
·
April 25, 2025
Explore how AI, big data, and telemedicine are revolutionizing healthcare in Tedrick Bairn’s groundbreaking new book, Digital Healthcare. NEW YORK, NY, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- As healthcare systems worldwide struggle with …
Decision Pulse AI By office solution : An GEN AI solution which outperform McKinsey BCG and BAIN consultant
EIN Presswire
·
April 25, 2025
GURUGRAM, HARYANA, INDIA, April 25, 2025 /EINPresswire.com/ -- Office Solution is excited to announce the availability of Decision Pulse AI on Microsoft AppSource, the trusted marketplace for business-ready applications. Built to empower enterprise …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …
H2Ocean Showcases Healing Innovation at ASPO 2025, Empowering Cancer Survivors Through Science
EIN Presswire
·
April 25, 2025
At the American Society of Preventive Oncology’s 49th Annual Meeting, H2Ocean’s Healing Rinse garners praise for tackling chemo mouth with sea salt science. STUART, FL, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- H2Ocean, the pioneer of sea salt …
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
GlobeNewswire
·
April 25, 2025
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
GlobeNewswire
·
April 25, 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in 1H-2026 VANCOUVER, British Columbia, April …
Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed …
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
GlobeNewswire
·
April 25, 2025
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancer Patient recruitment ongoing in Phase 1 trial of OP-3136 as a monotherapy and in …
Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets
GlobeNewswire
·
April 25, 2025
Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BRAF degrader demonstrates broad activity across all three BRAF mutation classes Aurora A kinase …
Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025
GlobeNewswire
·
April 25, 2025
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced today the presentation of a poster featuring new findings …